(Q46160400)

English

Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis

scientific article published on 25 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

author name string

Michael Pinkawa

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Marc D Piroth

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Branka Asadpour

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Bernd Gagel

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Karin Fischedick

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Jaroslav Siluschek

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Mareike Kehl

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Barbara Krenkel

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Michael J Eble

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

185

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

101-108

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

https://scigraph.springernature.com/pub.10.1007/s00066-009-1894-y

0 references

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1894-Y

21 January 2018

Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1894-Y

21 January 2018

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1894-Y

21 January 2018

Potency after permanent prostate brachytherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-1894-Y

21 January 2018

Organ movements and dose exposures in teletherapy of prostate cancer using a rectal balloon

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life after treatment for localized prostate cancer: differences based on treatment modality

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen kinetics after brachytherapy or external beam radiotherapy and neoadjuvant hormonal therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of second malignancies after prostate irradiation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes of dose delivery distribution within the first month after permanent interstitial brachytherapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term urinary quality of life after permanent prostate brachytherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Dosimetric impact of image-guided translational isocenter correction for 3-D conformal radiotherapy of the prostate]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transabdominal ultrasonography, computed tomography and electronic portal imaging for 3-dimensional conformal radiotherapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of care in the radiotherapy of prostate cancer in Northern Bavaria 1998-2000

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-institution results of primary external-beam radiation for the treatment of t1-t3 prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testosterone and erectile function recovery after radiotherapy and long-term androgen deprivation with luteinizing hormone-releasing hormone agonists.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiandrogens in the treatment of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late GI and GU complications in the treatment of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life after permanent interstitial brachytherapy for prostate cancer: correlation with postimplant CT scan parameters.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19240996

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-009-1894-Y

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19240996

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46160400&oldid=2095322974"